Hughes Eric A — SEC Form 4 filings

SEC reporting owner CIK 1938678. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.

Transaction summary — filings shown

Covers all 15 filings on record, filed 2024-03-05 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)See "Remarks"1213 legs · 305,685 sh · $7,053,54324
Monte Rosa Therapeutics, Inc. (GLUE)Director33

Form 4 filings — Hughes Eric A

FiledFormIssuerReported transactionsSource
2026-08-054TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 52,744 · Sale (S): 25,578 @ $34.88 · Option exercise (M): 52,744 (derivative) @ $0EDGAR
2026-06-124Monte Rosa Therapeutics, Inc. (GLUE)Grant/award (A): 25,800 (derivative) @ $0EDGAR
2026-03-094TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 19,654 · Sale (S): 9,533 @ $31.67 · Option exercise (M): 19,654 (derivative) @ $0EDGAR
2026-03-064TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 23,251 · Sale (S): 11,277 @ $32.46 · Option exercise (M): 23,251 (derivative) @ $0 · Grant/award (A): 50,643 (derivative) @ $0EDGAR
2026-03-054TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 24,900 · Sale (S): 12,077 @ $32.36 · Option exercise (M): 141,478 · Sale (S): 68,685 @ $32.36 · Option exercise (M): 24,900 (derivative) @ $0 · Option exercise (M): 141,478 (derivative) @ $0EDGAR
2026-01-294TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Grant/award (A): 141,478 (derivative) @ $0EDGAR
2025-08-054TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 52,742 · Sale (S): 52,742 @ $15.16 · Option exercise (M): 52,742 (derivative) @ $0EDGAR
2025-06-164Monte Rosa Therapeutics, Inc. (GLUE)Grant/award (A): 30,700 (derivative) @ $0EDGAR
2025-03-074TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Grant/award (A): 78,616 (derivative) @ $0EDGAR
2025-03-064TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 23,251 · Sale (S): 15,174 @ $15.73 · Sale (S): 8,077 @ $15.91 · Option exercise (M): 23,251 (derivative) @ $0EDGAR
2025-03-054TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 24,900 · Sale (S): 19,726 @ $16.19 · Sale (S): 5,174 @ $15.56 · Option exercise (M): 24,900 (derivative) @ $0EDGAR
2024-12-134Monte Rosa Therapeutics, Inc. (GLUE)Grant/award (A): 44,200 (derivative) @ $0EDGAR
2024-08-134TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Sale (S): 45,060 @ $17.38EDGAR
2024-08-054TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 52,742 · Sale (S): 24,537 @ $17.25 · Option exercise (M): 52,742 (derivative) @ $0EDGAR
2024-03-054TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)Option exercise (M): 24,900 · Sale (S): 8,045 @ $13.34 · Option exercise (M): 24,900 (derivative) @ $0 · Grant/award (A): 93,005 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1938678 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →